Bioretec
Bioretec pioneers biodegradable implants that resorb naturally, promoting bone healing while eliminating removal surgeries, transforming orthopedic care for patients worldwide.
Bioretec, a Finnish medical device innovator, specializes in biodegradable orthopedic implants designed to improve surgical outcomes and accelerate bone healing. With a mission to advance patient care through groundbreaking materials and technologies, Bioretec operates globally, serving healthcare providers in approximately 40 countries.
The company is pioneering its next-generation RemeOs™ product line, crafted from a magnesium alloy and hybrid composite. These innovative implants are designed to resorb naturally and be replaced by bone, eliminating the need for removal surgery while promoting efficient fracture healing. This approach positions RemeOs™ as a transformative alternative to titanium implants, aligning with Value-Based Healthcare objectives by enhancing patient outcomes and reducing healthcare costs.
Bioretec achieved a significant milestone in March 2023 with the U.S. market authorization for its first RemeOs™ product, and the CE mark approval process is underway in Europe. With a clear focus on the global orthopedic trauma and spine market—an industry valued at over USD 9 billion—Bioretec is poised to redefine the standards of surgical bone fracture treatment.
